ArticleMetabolites2026
Investigation of Storage Conditions and Quality Control Markers for Metabolites and Lipids in Human Feces.
Hiroshi Sawada, Motohiko Morihara, Masamitsu Gotou, Kazuyuki Fujii, Yuya Hidoh, Yasuhiro Sawai, Takashi Matsumoto, Taiki Nakaya, Osamu Miura, Tomohiro Ando and 2 more
Abstract read
In one paragraphArticle in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Hiroshi SawadaOtsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima, Tokushima 771-0192, Japan.
Motohiko MoriharaJapan Microbiome Consortium (JMBC), 3-1 Ofukacho, Kita-ku, Osaka, Osaka 530-0011, Japan.
Masamitsu GotouJapan Microbiome Consortium (JMBC), 3-1 Ofukacho, Kita-ku, Osaka, Osaka 530-0011, Japan.
Kazuyuki FujiiOtsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima, Tokushima 771-0192, Japan.ORCID 0000-0001-7627-3441 Yuya HidohOtsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima, Tokushima 771-0192, Japan.ORCID 0009-0005-5774-7521 Yasuhiro SawaiOtsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima, Tokushima 771-0192, Japan.ORCID 0009-0003-9555-6772 Takashi MatsumotoJapan Microbiome Consortium (JMBC), 3-1 Ofukacho, Kita-ku, Osaka, Osaka 530-0011, Japan.ORCID 0000-0003-2653-5372 Taiki NakayaJapan Microbiome Consortium (JMBC), 3-1 Ofukacho, Kita-ku, Osaka, Osaka 530-0011, Japan.
Osamu MiuraAxcelead Drug Discovery Partners, Inc., 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-0012, Japan.
Tomohiro AndoAxcelead Drug Discovery Partners, Inc., 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-0012, Japan.
Kazutaka IkedaKazusa DNA Research Institute, 2-6-7 Kazusa-kamatari, Kisarazu, Chiba 292-0818, Japan.ORCID 0000-0001-9247-4593 Jun TerauchiJapan Microbiome Consortium (JMBC), 3-1 Ofukacho, Kita-ku, Osaka, Osaka 530-0011, Japan.
Funding
Japan Microbiome Consortium (JMBC) No number
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
human feceslipidmetabolitequality control markerstorage condition
Identifiers
PMID41745596
PMCPMC12942472
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390